If this SPL consists of inactivated NDCs stated with the FDA initiated compliance action, They are going to be specified as a result.If withdrawal signs or symptoms crop up, it may be required to pause the taper for any length of time or raise the dose in the opioid analgesic to the preceding dose, and then proceed with a slower taper. Furthermore,